Georgetown Lombardi Visiting Professor and Grand Rounds Lecture Series Featuring Katherine Crew, MD
“Addressing Barriers to Breast Cancer Chemoprevention: Opportunities for Implementation into Clinical Practice”
Presented by:
Katherine Crew, MD
Columbia University
Sponsor: Dr. Kenneth Tercyak
Dr. Katherine Crew is associate professor of medicine and epidemiology at Columbia University Irving Medical Center and Director of the Clinical Breast Cancer Prevention Program for the Herbert Irving Comprehensive Cancer Center. She did all of her medical training at Columbia University and currently works as a medical oncologist in the Division of Hematology and Oncology with expertise in breast cancer. She is also a physician-scientist with funding from the National Cancer Institute, American Cancer Society, and the American Society of Clinical Oncology.
Dr. Crew is conducting research on breast cancer chemoprevention among high-risk women and identifying modifiable risk biomarkers, which can predict breast cancer risk and response to chemopreventive agents. She has been the PI or co-investigator of several early phase breast cancer chemoprevention trials, including a multicenter randomized controlled trial of high-dose vitamin D in premenopausal women at high-risk for breast cancer, SWOG 0812, with change in mammographic density as the primary outcome. She currently leads two multi-PI R01 grants to increase breast cancer chemoprevention using health information technology, including SWOG 1904, Making Informed Choices On Incorporating Chemoprevention into Care (MiCHOICE). She currently serves as Executive Officer for the SWOG Prevention, Survivorship, and Palliative Care Committees, Chair of the NCI Cancer Prevention and Control Central IRB, and a standing member of the NCI Cancer Prevention Study Section.
Lecture Series Presented by Georgetown Lombardi Comprehensive Cancer Center